FibroBiologics, Inc.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 455 E. MEDICAL CENTER BLVD, HOUSTON, TX, 77598
Mailing Address 455 E. MEDICAL CENTER BLVD SUITE 300, HOUSTON, TX, 77598
Phone 281-671-5150
Fiscal Year End 1231
EIN 863329066
Financial Overview
FY2024
$16.45M
Total Assets
$13.71M
Total Liabilities
$13.98M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | February 6, 2026 | View on SEC |
| 8-K Current report of material events | January 2, 2026 | View on SEC |
| DEF 14A Definitive proxy statement | December 29, 2025 | View on SEC |
| S-1 IPO registration statement | December 23, 2025 | View on SEC |
| DEF 14A Definitive proxy statement | December 18, 2025 | View on SEC |
| 424B5 Prospectus supplement | December 15, 2025 | View on SEC |
| 8-K Current report of material events | December 15, 2025 | View on SEC |
| 4 Insider stock transaction report | December 12, 2025 | View on SEC |
| 8-K Current report of material events | November 25, 2025 | View on SEC |
| 424B5 Prospectus supplement | November 25, 2025 | View on SEC |
Material Events
8-K Financial Distress February 6, 2026
High Impact
- FibroBiologics faces dual Nasdaq non-compliance for failing to maintain a minimum share price ($1.00) and market value ($35 million).
- The company has proposed a reverse stock split (ranging from 1-for-5 to 1-for-30 shares) to regain compliance with Nasdaq rules.
8-K Financial Distress January 2, 2026
High Impact
- FibroBiologics received a serious warning that its shares might be removed from the Nasdaq stock exchange due to its stock price being too low for too long.
- The company's stock price has consistently traded below $1.00 per share, violating Nasdaq's minimum bid price rule.
Insider Trading
BUY 1 insiders
1 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.